价格

H-7

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CRYSTALLINE FORM OF LORLATINIB FREE BASE
EP 3328867 A1申请人: PFIZER优先权: 2015
CN
EP
US
WO
10 件公开
Derivatives of piperidinyl-and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
US 7214798 B2申请人: SANOFI AVENTIS优先权: 2003
CN
US
6 件公开
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
US 9067936 B2申请人: DEMONT EMMANUEL HUBERT优先权: 2011
EP
US
5 件公开
Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes
EP 1754484 A1申请人: STOICESCU DAN优先权: 2005
EP
US
4 件公开
COMPOUND FOR TREATMENT OF CANCER
EP 2959900 B1申请人: UNIV TENNESSEE RES FOUND优先权: 2008
CN
EP
4 件公开
EP2 receptor agonists
US 7326732 B2申请人: PHARMAGENE LAB LTD优先权: 2005
US
4 件公开
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US 9259426 B2申请人: GAO LING-JIE优先权: 2007
US
4 件公开
3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS
EP 4605390 A1申请人: KALVISTA PHARMACEUTICALS LTD优先权: 2022
EP
US
WO
3 件公开
2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
US 20260137703 A1申请人: CANCER RESEARCH TECH LTD优先权: 2022
EP
US
WO
3 件公开
A MACROLIDE FOR USE IN A METHOD OF PREVENTING OR TREATING AN IMMUNOLOGICAL DISEASE OR DISORDER
- EP 4661871 A1
  申请人: NUCLEUS MEDICAL GMBH优先权: 2023
  EP
  US
  WO
  3 件公开
- EP 4410287 A1
  申请人: NUCLEUS MEDICAL GMBH优先权: 2023
  EP

药物

H-7

专利

A MACROLIDE FOR USE IN A METHOD OF PREVENTING OR TREATING AN IMMUNOLOGICAL DISEASE OR DISORDER